Monoclonal antibody therapies will be the first drugs permitted to take advantage of alternatives, including advanced lab simulations and artificial intelligence. A pilot framework to phase out the decades-long requirement for animal testing will be rolled out in the coming year, the FDA said.

RBMA board member Kit Crancer offers an update on Medicare reform and advocacy in Congress and how medical societies may be able to get more traction in state legislatures.
 

The algorithm can be applied to noncontrast abdominal CT scans completed for any clinical indication.

The Department of Health and Human Services is looking to replace lab animals with AI models. Even more bullish on AI is the new boss at the Centers for Medicare and Medicaid Services. 

Andrew Colbert, senior managing director of Ziegler, spoke at RBMA 2025, discussing teleradiology's "explosive" growth, among other developments. 

The Health Tech Investment Act will place all FDA-approved AI devices into the Hospital Outpatient Prospective Payment System for a minimum of five years.  

HHS charges that New York state-based Northeast Radiology failed to conduct a thorough risk analysis of its systems, which may have prevented the PACS breach. 

Despite the improvement, physicians remain at greater risk for such workplace fatigue when compared to other professions, the AMA reports.